News
Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections and, in ...
Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...
Molbreevi – a new inhaled formulation of the well-established and off-patent white blood cell stimulator molgramostim – is ...
The only available treatment for a patient with coeliac disease is a strict gluten-free diet, which is often not enough on ...
Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...
In another signal of downgraded support for COVID-19 vaccination programmes under the Trump administration, the CDC has ...
The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...
The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, ...
Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...
Sanofi has been given a reprimand by the UK's Prescription Medicines Code of Practice Authority (PMCPA), after admitting that ...
The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...
President Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results